Barclays analyst Luke Sergott lowered the firm’s price target on Thermo Fisher (TMO) to $610 from $620 and keeps an Equal Weight rating on the shares. The company reported an in-line quarter among elevated expectations, the analyst tells investors in a research note. The firm sees solid execution in a “very tough” tools demand environment with low visibility into the demand recovery.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher Scientific Reports Earnings: Did it Beat Estimate Forecasts?
- Thermo Fisher price target lowered to $610 from $620 at Barclays
- Thermo Fisher sees Q4 EPS $5.96, consensus $5.98
- Morning Movers: AT&T rises and Coca-Cola falls following quarterly reports
- Thermo Fisher reports Q3 adjusted EPS $5.28, consensus $5.24